Ribosomal protein L32 pseudogene 4 (RPL32P4)

Ribosomal protein L32 pseudogene 4 (RPL32P4) is a non-protein-coding genetic element classified as a processed pseudogene and member of the ribosomal protein L32 family. Pseudogenes like RPL32P4 are DNA sequences similar to functional genes but typically lack protein-coding potential due to accumulated mutations or truncations. RPL32P4 does not produce a functional protein, nor does it act as a receptor, transporter, enzyme, transcription factor, or known molecular drug target in any validated preclinical or clinical setting[1][8][11]. While some ribosomal protein pseudogenes have been investigated for possible regulatory functions or involvement in cancer, RPL32P4 specifically lacks published evidence of biological activity or therapeutic relevance. Its significance is strictly limited to genome architecture and evolutionary studies[8][9]. Given this classification, RPL32P4 is not a therapeutic target, does not fit conventional molecular family definitions (such as receptor, enzyme, etc.), and has no associated drugs, biomarkers, or safety profiles[1][8].

Other names

RPL32LRPL32_11_924RPL32P4